Prazocillin

This classification denotes a penicillin antibiotic with the molecular formula C19H18Cl2N4O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier IRZ1462XXF, chemically known as 6-(1-(2,6-dichlorophenyl)-4-methylpyrazole-5-carboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid but generally known as prazocillin, which bears US NIH Compound Identifier 65622. European Medicines Agency schedules Prazocillin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10010MIG. The term PRAZOCILLIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 28, No. 10 1974, List 14). PRAZOCILLIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule prazocillin under HS 29411090 and SITC 54131. As of Q4 2014, PRAZOCILLIN remains the US FDA Preferred Term for this commodity. Prazocillin bears US NLM identifiers UMLS ID C0071817 and NCI Concept Code C72832. SMILES: Clc1c(n2ncc(c2C(=O)NC2C3SC(C(N3C2=O)C(=O)O)(C)C)C)c(Cl)ccc1.